Ovid Therapeutics Inc (NASDAQ:OVID)
| 3.79 Delayed Data As of 3:59pm ET |  +0.05 / +1.34%Today’s Change | 2.25 Today|||52-Week Range 8.37 | +64.07% Year-to-Date |
Latest OVID News | Press Releases
No recent news for Ovid Therapeutics Inc.
Today’s Trading
| Previous close | 3.74 |
| Today’s open | 3.79 |
| Day’s range | 3.74 - 3.82 |
| Volume | 12,904 |
| Average volume (3 months) | 814,091 |
| Market cap | $255.0M |
Data as of 3:59pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | +10.07% |
| Earnings growth (this year) | +251.87% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 2.5 |
| Price/Sales | 10.70 |
| Price/Book | 5.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PRTKParatek Pharmaceutic... | +0.19 | +3.58% |
| PDSBPDS Biotechnology Co... | +0.79 | +8.48% |
| MBIOMustang Bio Inc | +0.03 | +1.06% |
| ABUSArbutus Biopharma Co... | +0.10 | +3.72% |
Data as of 3:59pm ET, 07/28/2021
Financials
| Next reporting date | August 12, 2021 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $12.6M |
| Annual profit (last year) | -$81.0M |
| Net profit margin | -642.26% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
